Saitoh Y, Yoshimoto T, Kato S, Miwa N
Laboratory of Bioscience & Biotechnology for Cell Function Control, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 562 Nanatsuka, Shobara, Hiroshima 727-0023, Jap.
Radioisotope Facilities for Medical Science, Life Science Research Center, Mie University, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Exp Oncol. 2015 Jun;37(2):94-9.
In this study, we evaluated the carcinostatic effects of combined ascorbic acid (AsA) and a capacitive-resistive electric transfer (CRet) hyperthermic apparatus-induced hyperthermic treatment on Ehrlich ascites tumor (EAT) cells.
EAT cells were exposed to various AsA (0-10 mM) concentrations for 1 h; they subsequently underwent CRet treatment for 15 min at 42 °C. Cell viability was assessed by the WST-8 assay 24 h after the combined treatment. Reactive oxygen species involvement was evaluated using catalase and tempol; caspase-3/7 activation was determined by their fluorescent substrates; cell proliferation were estimated by time-lapse observation. The effect on the cell cycle was analyzed by flow cytometry.
Combined AsA and CRet treatment synergistically suppressed cell viability compared with either treatment alone, and these synergistically carcinostatic effects were evident even at noncytotoxic concentrations of AsA alone (≤ 2 mM). The carcinostatic effects of combined AsA and CRet treatment were attenuated in a dose-dependent manner by catalase addition, but not by the superoxide anion radical scavenger tempol. Time-lapse observation revealed that combined AsA and CRet treatment activated caspase-3/7 at 10-24 h after treatment, accompanied by significant cell growth suppression. Cell cycle analysis revealed that the rate of sub-G1-phase (apoptotic) cells was drastically increased at 12 h and 24 h, and that the G2/M-phase cells gradually increased at 6-24 h after treatment.
These results indicate that combined AsA and CRet treatment synergistically inhibits EAT cell growth through G2/M arrest and apoptosis induction via H2O2 generation at lower AsA concentrations; this carcinostatic effect cannot be exerted by AsA alone.
在本研究中,我们评估了联合抗坏血酸(AsA)和电容电阻式电转移(CRet)热疗设备诱导的热疗对艾氏腹水瘤(EAT)细胞的抑癌作用。
将EAT细胞暴露于不同浓度的AsA(0 - 10 mM)中1小时;随后在42℃下进行CRet处理15分钟。联合处理24小时后,通过WST - 8法评估细胞活力。使用过氧化氢酶和Tempol评估活性氧的参与情况;通过其荧光底物测定caspase - 3/7的激活情况;通过延时观察估计细胞增殖。通过流式细胞术分析对细胞周期的影响。
与单独的任何一种处理相比,联合AsA和CRet处理协同抑制细胞活力,并且即使在单独使用AsA的非细胞毒性浓度(≤2 mM)下,这些协同抑癌作用也很明显。添加过氧化氢酶以剂量依赖性方式减弱了联合AsA和CRet处理的抑癌作用,但超氧阴离子自由基清除剂Tempol没有这种作用。延时观察显示,联合AsA和CRet处理在处理后10 - 24小时激活了caspase - 3/7,同时伴随着明显的细胞生长抑制。细胞周期分析显示,在处理后12小时和24小时,亚G1期(凋亡)细胞的比例急剧增加,并且在处理后6 - 24小时,G2/M期细胞逐渐增加。
这些结果表明,联合AsA和CRet处理通过在较低AsA浓度下通过产生H2O2诱导G2/M期阻滞和凋亡,协同抑制EAT细胞生长;这种抑癌作用不能仅由AsA单独发挥。